These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 150029)

  • 1. [Hodgkin's disease: classification, staging, therapy].
    Wewerka JR
    Schweiz Med Wochenschr; 1978 Aug; 108(32):1241-6. PubMed ID: 150029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances and controversies in the management of Hodgkin's disease.
    O'Brien PH; Wallace K; Rambo VB
    Surg Gynecol Obstet; 1975 Mar; 140(3):445-51. PubMed ID: 803722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Laparotomy in the therapy of Hodgkin's disease].
    Bauters F; Jouet JP; Caulier MT; Wurtz A; Ribet M; Goudemand M
    Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):495-502. PubMed ID: 917838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric Hodgkin's disease.
    Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM
    J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective splenectomy in Hodgkin's disease, stages I and II. Results of treatment.
    Berkowicz M; Rath P; Aghai E; Many A; Ben-Bassat I; Hulu N; Ramot B; Brenner H
    Isr J Med Sci; 1978 Dec; 14(12):1275-82. PubMed ID: 748241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemotherapy-radiotherapy association in the treatment of localized forms of Hodgkin's disease. Prognosis of polychemotherapy after three trials of M.O.P.P].
    Baillet F; Brun B; Mazeron JJ; Rochant H; Pinon G; Reyes F; Vernant JP; Pierquin B; Dreyfus B
    Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):457-61. PubMed ID: 917834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current trend in the treatment of Hodgkin's disease.
    Tubiana M; Amiel JL; Hayat M; Henry-Amar M; Cosset JM; Droz JP; Carde P
    Radiat Med; 1983; 1(3):221-9. PubMed ID: 6390537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of Hodgkin's disease stages I, II, and III].
    Teillet F; Bayle-Weisgerber C; Andrieu JM
    Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):485-94. PubMed ID: 917837
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug therapy of Hodgkin's disease].
    Gallmeier WM; Bruntsch U
    Internist (Berl); 1981 May; 22(5):289-300. PubMed ID: 7019138
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combination chemotherapy (MOPP) in 60 patients with Hodgkin's disease (five years results) (author's transl)].
    Lauria F; Baccarani M; Barbieri E; Fiacchini M; Gobbi M; Tura S; Baccarani M
    Haematologica; 1975 Mar; 60(1):73-84. PubMed ID: 806500
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hodgkin's disease: treatment of clinical stages II3+A, IB, IIB, IIIA and IIIB with short chemotherapy (3 MOPP, or 3 CVPP), splenectomy and limited irradiation. Results after 4 years of a prospective protocol including 94 patients].
    Andrieu JM; Casassus P; Coscas Y; Darmont J; Goubeau C; Katz M; Jacquillat C; Tricot G; Weil M
    Bull Cancer; 1982; 69(4):321-9. PubMed ID: 6897520
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of Hodgkin's disease.
    Desforges JF; Rutherford CJ
    Compr Ther; 1979 Feb; 5(2):63-9. PubMed ID: 428209
    [No Abstract]   [Full Text] [Related]  

  • 13. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results with MOPP combination chemotherapy in Hodgkin's disease (author's transl)].
    Neumann E
    Wien Klin Wochenschr; 1981 Feb; 93(4):134-7. PubMed ID: 6895134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comments about use of polychemotherapy MOPP associated with radiotherapy in the treatment of early stages of Hodgkin's disease. Preliminary report of 58 patients (author's transl)].
    Brun B; Alaoui Y; Kuentz M; Baillet F; Maylin C; Vernant JP; Reyes F; Rochant H; Pierquin B; Dreyfus B
    Ann Med Interne (Paris); 1980; 131(4):239-43. PubMed ID: 7425449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of combined chemotherapy (MOPP) in the treatment of patients with generalized Hodgkin's disease].
    Aghai E; Kende G; Many A; Ramot B
    Harefuah; 1974 Apr; 86(7):348-51. PubMed ID: 4846045
    [No Abstract]   [Full Text] [Related]  

  • 17. Splenectomy effects on chemotherapy in Hodgkin's disease.
    Panettiere F; Coltman CA
    Arch Intern Med; 1973 Mar; 131(3):362-6. PubMed ID: 4688035
    [No Abstract]   [Full Text] [Related]  

  • 18. [Relapses in Hodgkin's disease and their radiochemotherapy (author's transl)].
    Babini L; Sciascia R; Baccarani M; Emiliani E; Fiacchini M; Franchini A; Lauria F; Tura S
    Radiol Med; 1978 Feb; 64(2):113-8. PubMed ID: 684251
    [No Abstract]   [Full Text] [Related]  

  • 19. Towards curative treatment of advanced Hodgkin's disease.
    Falkson HC; Falkson G
    S Afr Med J; 1975 Sep; 49(38):1545-9. PubMed ID: 1179225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
    Mjaaland I; Ganser D; Freitag EM; Bohndorf W
    Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.